Pancreatic cancer

No abstract is available for this paper.

• Publication year

  1988

• Venue

  Nature Reviews Disease Primers

• Publication date

  1988-03-19

• Fields of study

  Medicine

• Identifiers
  DOI 10.1038/nrdp.2016.22PMID 27158978
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States

  2018cited by this paper
• Preoperative Evaluation and Anesthesia in Minimally Invasive Surgery of the Pancreas

  2018cited by this paper
• FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer

  2018cited by this paper
• Canadian Cardiovascular Society Guidelines on Perioperative Cardiac Risk Assessment and Management for Patients Who Undergo Noncardiac Surgery.

  2017cited by this paper
• "Radiological and Surgical Implications of Neoadjuvant Treatment With FOLFIRINOX for Locally Advanced and Borderline Resectable Pancreatic Cancer."

  2017cited by this paper
• Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial.

  2017cited by this paper
• Evolution of Pancreatic Cancer Surgery

  2017cited by this paper
• Diabetes, Pancreatogenic Diabetes, and Pancreatic Cancer

  2017cited by this paper
• Type 3c (pancreatogenic) diabetes mellitus secondary to chronic pancreatitis and pancreatic cancer.

  2016cited by this paper
• Current evidence for the diagnostic value of gadoxetic acid‐enhanced magnetic resonance imaging for liver metastasis

  2016cited by this paper
• Nanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy (NAPOLI-1): a global, randomised, open-label, phase 3 trial.

  2016cited by this paper
• p53 mutations cooperate with oncogenic Kras to promote adenocarcinoma from pancreatic ductal cells

  2016cited by this paper
• Meta‐analysis of benefits of portal–superior mesenteric vein resection in pancreatic resection for ductal adenocarcinoma

  2016cited by this paper
• Genomic analyses identify molecular subtypes of pancreatic cancer

  2016cited by this paper
• Targeted Screening of Individuals at High Risk for Pancreatic Cancer: Results of a Simulation Model.

  2016cited by this paper
• Pancreatic cancer-associated retinoblastoma 1 dysfunction enables TGF-β to promote proliferation.

  2016cited by this paper
• Adjuvant gemcitabine alone versus gemcitabine-based chemoradiation after curative resection for pancreatic cancer: Updated results of a randomized EORTC/FFCD/GERCOR phase II study (40013-22012/9203).

  2016cited by this paper
• The principles of cancer staging

  2016cited by this paper
• [Early detection of sporadic pancreatic cancer].

  2016cited by this paper
• Total pancreatectomy for primary pancreatic neoplasms: renaissance of an unpopular operation.

  2015cited by this paper
• Minimally Invasive Versus Open Pancreaticoduodenectomy for Cancer: Practice Patterns and Short-term Outcomes Among 7061 Patients.

  2015cited by this paper
• Cancers in Australia in 2010 attributable to modifiable factors: introduction and overview

  2015cited by this paper
• PD-1/PD-L1 Blockade Together With Vaccine Therapy Facilitates Effector T-Cell Infiltration Into Pancreatic Tumors

  2015cited by this paper
• Randomized Phase Ib/II Study of Gemcitabine Plus Placebo or Vismodegib, a Hedgehog Pathway Inhibitor, in Patients With Metastatic Pancreatic Cancer

  2015cited by this paper
• Central adiposity, obesity during early adulthood, and pancreatic cancer mortality in a pooled analysis of cohort studies.

  2015cited by this paper
• European cancer mortality predictions for the year 2015: does lung cancer have the highest death rate in EU women?

  2015cited by this paper
• Whole genomes redefine the mutational landscape of pancreatic cancer

  2015cited by this paper
• Patient-centric trials for therapeutic development in precision oncology

  2015cited by this paper
• Safety and survival with GVAX pancreas prime and Listeria Monocytogenes-expressing mesothelin (CRS-207) boost vaccines for metastatic pancreatic cancer.

  2015cited by this paper
• Subtyping Pancreatic Cancer.

  2015cited by this paper
• Linear-array EUS improves detection of pancreatic lesions in high-risk individuals: a randomized tandem study.

  2015cited by this paper
• Physical activity and risk of pancreatic cancer: a systematic review and meta-analysis

  2015cited by this paper
• Ibrutinib exerts potent antifibrotic and antitumor activities in mouse models of pancreatic adenocarcinoma.

  2015cited by this paper
• PD-1 Blockade in Tumors with Mismatch-Repair Deficiency.

  2015cited by this paper
• Extended Versus Standard Lymphadenectomy for Pancreatic Head Cancer: Meta-Analysis of Randomized Controlled Trials

  2015cited by this paper
• Radiological and surgical implications of neoadjuvant treatment with FOLFIRINOX for locally advanced and borderline resectable pancreatic cancer.

  2015cited by this paper
• Faculty Opinions recommendation of Elevation of circulating branched-chain amino acids is an early event in human pancreatic adenocarcinoma development.

  2015cited by this paper
• A systematic review and meta-analysis of laparoscopic versus open distal pancreatectomy for benign and malignant lesions of the pancreas: it's time to randomize.

  2015cited by this paper
• Whole-exome sequencing of pancreatic cancer defines genetic diversity and therapeutic targets

  2015cited by this paper
• Virtual microdissection identifies distinct tumor- and stroma-specific subtypes of pancreatic ductal adenocarcinoma

  2015cited by this paper
• Anti-cancer effects of oncolytic viral therapy combined with photodynamic therapy in human pancreatic cancer cell lines.

  2015cited by this paper
• Targeted screening of individuals at high risk for pancreatic cancer: results of a simulation model.

  2015cited by this paper
• Human pancreatic cancer tumors are nutrient poor and tumor cells actively scavenge extracellular protein.

  2015cited by this paper
• Exclusion of T Cells From Pancreatic Carcinomas in Mice Is Regulated by Ly6C(low) F4/80(+) Extratumoral Macrophages.

  2015cited by this paper
• Hypoxia signaling pathways: modulators of oxygen-related organelles

  2015cited by this paper
• Meta‐analysis of radical resection rates and margin assessment in pancreatic cancer

  2015cited by this paper
• The Cancer Genome Atlas(TCGA)Data Portalを用いた胃癌の予後不良に関連した遺伝子検索

  2015cited by this paper
• Population Attributable Risk for Pancreatic Cancer in Northern Italy

  2015cited by this paper
• A multicentre comparative prospective blinded analysis of EUS and MRI for screening of pancreatic cancer in high-risk individuals

  2015cited by this paper
• Metabolite profiling stratifies pancreatic ductal adenocarcinomas into subtypes with distinct sensitivities to metabolic inhibitors

  2015cited by this paper
• FDG PET/CT in Pancreatic and Hepatobiliary Carcinomas: Value to Patient Management and Patient Outcomes.

  2015cited by this paper
• Early Detection of Sporadic Pancreatic Cancer

  2015cited by this paper
• TLR9 ligation in pancreatic stellate cells promotes tumorigenesis

  2015cited by this paper
• The Role of End-of-Life Issues in the Design and Reporting of Cancer Clinical Trials: A Structured Literature Review

  2015cited by this paper
• Pancreatic cancer and thromboembolic disease, 150 years after Trousseau.

  2015cited by this paper
• Glypican-1 identifies cancer exosomes and detects early pancreatic cancer

  2015cited by this paper
• Cost Efficacy of Metal Stents for Palliation of Extrahepatic Bile Duct Obstruction in a Randomized Controlled Trial.

  2015cited by this paper
• Detectable Symptomatology Preceding the Diagnosis of Pancreatic Cancer and Absolute Risk of Pancreatic Cancer Diagnosis.

  2015cited by this paper
• Transcriptional control of autophagy–lysosome function drives pancreatic cancer metabolism

  2015cited by this paper
• The microsatellite instable subset of colorectal cancer is a particularly good candidate for checkpoint blockade immunotherapy.

  2015cited by this paper
• Depletion of Carcinoma-Associated Fibroblasts and Fibrosis Induces Immunosuppression and Accelerates Pancreas Cancer with Reduced Survival.

  2015cited by this paper
• Trends in Hospital Volume and Failure to Rescue for Pancreatic Surgery

  2015cited by this paper
• Organoid models of human and mouse ductal pancreatic cancer.

  2015cited by this paper
• Preoperative modified FOLFIRINOX (mFOLFIRINOX) followed by chemoradiation (CRT) for borderline resectable (BLR) pancreatic cancer (PDAC): Initial results from Alliance Trial A021101.

  2015cited by this paper
• Cancer statistics, 2015

  2015cited by this paper
• Pancreatic cancer modeling using retrograde viral vector delivery and in vivo CRISPR/Cas9-mediated somatic genome editing

  2015cited by this paper
• Randomized, Double-Blind, Phase II Study of Ruxolitinib or Placebo in Combination With Capecitabine in Patients With Metastatic Pancreatic Cancer for Whom Therapy With Gemcitabine Has Failed.

  2015cited by this paper
• Hypoxia-induced endoplasmic reticulum stress characterizes a necrotic phenotype of pancreatic cancer

  2015cited by this paper
• The prognostic role of desmoplastic stroma in pancreatic ductal adenocarcinoma

  2015cited by this paper
• A Revised Classification System and Recommendations From the Baltimore Consensus Meeting for Neoplastic Precursor Lesions in the Pancreas

  2015cited by this paper
• Cross-Species Antibody Microarray Interrogation Identifies a 3-Protein Panel of Plasma Biomarkers for Early Diagnosis of Pancreas Cancer

  2015cited by this paper
• Pain management of pancreatic head adenocarcinomas that are unresectable: celiac plexus neurolysis and splanchnicectomy.

  2015cited by this paper
• Thirty Years of Experience with Intraductal Papillary Mucinous Neoplasm of the Pancreas: From Discovery to International Consensus

  2015cited by this paper
• Targeting cancer cell metabolism in pancreatic adenocarcinoma

  2015cited by this paper
• Gene signatures from pancreatic cancer tumor and stromal cells predict disease outcome

  2015cited by this paper
• Health-Related Quality of Life in SCALOP, a Randomized Phase 2 Trial Comparing Chemoradiation Therapy Regimens in Locally Advanced Pancreatic Cancer

  2015cited by this paper
• Clinical implications of genomic alterations in the tumour and circulation of pancreatic cancer patients

  2015cited by this paper
• Current and future care of patients with the cancer anorexia-cachexia syndrome.

  2015cited by this paper
• High response rate and PFS with PEGPH20 added to nab-paclitaxel/gemcitabine in stage IV previously untreated pancreatic cancer patients with high-HA tumors: Interim results of a randomized phase II study.

  2015cited by this paper
• The prognostic value of stroma in pancreatic cancer in patients receiving adjuvant therapy.

  2015cited by this paper
• Resectability After First-Line FOLFIRINOX in Initially Unresectable Locally Advanced Pancreatic Cancer: A Single-Center Experience

  2015cited by this paper
• Distal pancreatectomy with celiac axis resection: what are the added risks?

  2015cited by this paper
• Mining the genomes of exceptional responders

  2014cited by this paper
• The role of the hepatocyte growth factor/c-MET pathway in pancreatic stellate cell-endothelial cell interactions: antiangiogenic implications in pancreatic cancer.

  2014cited by this paper
• Hypoxia-inducible factor 1α expression and its clinical significance in pancreatic cancer: a meta-analysis.

  2014cited by this paper
• Elevated circulating branched chain amino acids are an early event in pancreatic adenocarcinoma development

  2014cited by this paper
• Autophagy is critical for pancreatic tumor growth and progression in tumors with p53 alterations.

  2014cited by this paper
• Pancreatic adenocarcinoma, version 2.2014: featured updates to the NCCN guidelines.

  2014cited by this paper
• Depletion of carcinoma-associated fibroblasts and fibrosis induces immunosuppression and accelerates pancreas cancer with reduced survival.

  2014cited by this paper
• Immunotherapy Converts Nonimmunogenic Pancreatic Tumors into Immunogenic Foci of Immune Regulation

  2014cited by this paper
• Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States.

  2014cited by this paper
• Pancreatic cancer-associated retinoblastoma 1 dysfunction enables TGF-β to promote proliferation.

  2014cited by this paper
• The chromatin regulator Brg1 suppresses formation of intraductal papillary mucinous neoplasm and pancreatic ductal adenocarcinoma

  2014cited by this paper
• Pancreatic Cancer‐Induced Cachexia Is Jak2‐Dependent in Mice

  2014cited by this paper
• Sequential neoadjuvant chemoradiotherapy (CRT) followed by curative surgery vs. primary surgery alone for resectable, non-metastasized pancreatic adenocarcinoma: NEOPA- a randomized multicenter phase III study (NCT01900327, DRKS00003893, ISRCTN82191749)

  2014cited by this paper
• Vitamin D receptor-mediated stromal reprogramming suppresses pancreatitis and enhances pancreatic cancer therapy.

  2014cited by this paper
• Minimally-invasive vs open pancreaticoduodenectomy: systematic review and meta-analysis.

  2014cited by this paper
• Fibrogenesis in pancreatic cancer is a dynamic process regulated by macrophage-stellate cell interaction

  2014cited by this paper
• Neuroplastic changes occur early in the development of pancreatic ductal adenocarcinoma.

  2014cited by this paper
• Pancreatic cancer stroma: friend or foe?

  2014cited by this paper

• A humanized LIF-targeting antibody synergistically enhances chemo- and immunotherapy in pancreatic cancer

  2026influential citation
• VISTA drives pancreatic tumor progression through modulation of the tumor-associated macrophage polarity.

  2026cites this paper
• 5'-NucA-SMCC-DM1 and 5'-NucA-SPDMV-DM1 are Potent Aptamer-Drug Conjugates against Pancreatic Cancer.

  2026cites this paper
• SOX8 mediates the crosstalk between KRAS and TGF-β pathways to promote the malignant progression of pancreatic cancer.

  2026cites this paper
• Diagnostic efficacy of blood biomarkers for differentiating early-stage pancreatic cancer from chronic pancreatitis: A systematic review and network meta-analysis

  2026cites this paper
• Palmaturbine Inhibits Pancreatic Ductal Adenocarcinoma by Suppressing the JAK2/STAT3 Signaling Pathway.

  2026cites this paper
• Early diagnosis of pancreatic ductal adenocarcinoma by signal-enhanced lateral flow immunoassay: SELFI.

  2026cites this paper
• Multi-Omic and Spatial Profiling Identifies an Epithelial DKK1 Associated with Microenvironmental Remodeling in Pancreatic Ductal Adenocarcinoma.

  2026cites this paper
• Targeted photodynamic therapy for pancreatic cancer: recent innovations from fundamentals to in vivo and clinical applications (2020-2025).

  2026cites this paper
• Global research status and trends in venous thromboembolism and pancreatic cancer: a bibliometric analysis

  2026cites this paper
• Evaluation of TRAM@PPF Nanoparticles for Efficacy Against Pancreatic Cancer in Mice Model.

  2026cites this paper
• Targeting the DDX3/PAF1 Axis Enhances Chemotherapy Efficacy in Pancreatic Ductal Adenocarcinoma.

  2026cites this paper
• Unlocking the Power of CXCR2 Inhibition to Overcome Gemcitabine Resistance in Pancreatic Cancer

  2026cites this paper
• Tumor cell derived CCL20 exacerbates the immunosuppressive microenvironment by recruiting CCR6+ Tregs in pancreatic cancer.

  2026cites this paper
• Management of Complications After Pancreaticoduodenectomy: A Narrative Review of Pathophysiology and Treatment Strategies.

  2026cites this paper
• Identification of HSPE1 as a new actionable cancer vulnerability leads to an innovative and effective combination therapy for pancreatic ductal adenocarcinoma.

  2026cites this paper
• Discovery of a Novel Dual-Targeting KRASG12D/HDAC Peptide Inhibitor for the Treatment of Pancreatic Cancer.

  2026cites this paper
• Pancreatic Circulating Tumor Cells: An Update

  2026cites this paper
• Discovery and Clinical Significance of 1p36 Chromosomal Aberrations in Differentiating Hepatocellular Carcinoma from Other Hepatobiliary Cancers.

  2026cites this paper
• Ultrasensitive Fluorescent Detection of Urinary Trypsin for Early Pancreatic Disease Diagnosis: Toward Smartphone-Assisted Analysis.

  2026cites this paper
• Head-to-head comparison of [177Lu]Lu-FAP-2286 and [161Tb]Tb-FAP-2286 efficacy in a PDAC mouse model

  2026cites this paper
• In situ multi-modal characterization of pancreatic cancer reveals tumor cell identity as a defining factor of the surrounding microenvironment.

  2026cites this paper
• T cells engineered against Dickkopf-1-A2 complex can be used to treat HLA-A2+ solid and hematologic cancers.

  2026cites this paper
• Targeted Nanoencapsulation of Tunicamycin Reduces Toxicity While Improving its Therapeutic Effectiveness in Pancreatic Cancer Cells

  2025cites this paper
• Rationally designed anti-autophagy nanosystems for reversing the immunosuppressive network in the tumor environment.

  2025cites this paper
• Toward diffusion MRI in the diagnosis and treatment of pancreatic cancer

  2025cites this paper
• Economic evaluations of early detection strategies for pancreatic cancer: a systematic review

  2025cites this paper
• 3D printed GelMA/HAMA based mechanical microenvironment boosted PDAC chemoresistance via NRF2-repressed ferroptosis.

  2025cites this paper
• Global, regional, and national burdens of pancreatic cancer attributable to smoking from 1990 to 2021 and the projections to 2035:a systematic analysis from the global burden of disease study 2021

  2025cites this paper
• Evaluation of the Cytotoxicity and Molecular Docking Properties of the Green Synthesis of Ag2S Nanoparticles

  2025cites this paper
• A Comprehensive Review on Revolutionizing Pancreatic Cancer Treatment: Liposomal Innovations

  2025cites this paper
• The potential application of stroma modulation in targeting tumor cells: focus on pancreatic cancer and breast cancer models.

  2025cites this paper
• Targeting myeloid cells in pancreatic ductal adenocarcinoma: from primary tumors to liver metastasis

  2025cites this paper
• Early-Stage Pancreatic Cancer Diagnosis: Serum Biomarkers and the Potential for Aptamer-Based Biosensors

  2025cites this paper
• CCN1 Enhances Tumor Immunosuppression through Collagen‐Mediated Chemokine Secretion in Pancreatic Cancer

  2025cites this paper
• Delivery of Ulva rigida extract by bicontinuous cubic lipid nanoplatforms for potential photodynamic therapy against pancreatic cancer.

  2025cites this paper
• Multiplexed Detection of Pancreatic-Specific Nucleic Acids and Protein Biomarkers Using a Logic Nanofluidic Platform.

  2025cites this paper
• Ultrasound-Triggered NPC1L1-Targeting Nanobubbles for Remodeling the Tumor Microenvironment in Pancreatic Cancer Chemoimmunotherapy

  2025cites this paper
• Deep Learning Methods in the Imaging of Hepatic and Pancreaticobiliary Diseases.

  2025cites this paper
• Claudin 18 (43–14A clone) expression in pancreatic ductal adenocarcinoma: Assessment of a potential clinical biomarker for zolbetuximab therapy

  2025cites this paper
• An Analysis of the mRNA Expression of Peripheral-Blood Stem and Progenitor Cell Markers in Pancreatic Neoplastic Disorders

  2025cites this paper
• Total lesion glycolysis is a promising predictor of chemo‐response in pancreatic cancer patients treated with neoadjuvant chemotherapy prior to surgery

  2025cites this paper
• Role of radiotherapy in surgical approaches to pancreatic cancer treatment: A narrative review

  2025cites this paper
• Therapie des Pankreaskarzinoms: Innovative Chirurgie und moderne Systemtherapien

  2025cites this paper
• Phenotypic heterogeneity and tumor immune microenvironment directed therapeutic strategies in pancreatic ductal adenocarcinoma

  2025cites this paper
• PLK1 blockade enhances the anti-tumor effect of MAPK inhibition in pancreatic ductal adenocarcinoma.

  2025cites this paper
• Unlocking the Genetic Secrets of Pancreatic Cancer: KRAS Allelic Imbalances in Tumor Evolution

  2025cites this paper
• Diagnostic yield of biliary brush cytology via ERCP - A 7-year tertiary center experience.

  2025cites this paper
• Current Organoid Culture Systems in Pancreatic Cancer.

  2025cites this paper
• Stevia Leaf Extract Fermented with Plant-Derived Lactobacillus plantarum SN13T Displays Anticancer Activity to Pancreatic Cancer PANC-1 Cell Line

  2025cites this paper
• Biomimetic nanosystems for pancreatic cancer therapy: A review.

  2025cites this paper
• Real-World Advances in Metastatic Pancreatic Cancer Treatment in the Pre-Molecular Era: A Retrospective Single-Center Analysis 2010–2018

  2025cites this paper
• CSF1-CAR Specifically Targets CSF1R+ Pancreatic Cancer Cells and Tumor-Associated Macrophages.

  2025cites this paper
• Synergizing photodynamic therapy and ethanol ablation: Light‐activatable sustained‐exposure ethanol injection technology for enhanced tumor ablation

  2025cites this paper
• CLDN18.2 CAR‐derived Extracellular Vesicle Immunotherapy Improves Outcome in Murine Pancreatic Cancer

  2025cites this paper
• ARHGAP11A is a potential prognostic biomarker and therapeutic target for pancreatic adenocarcinoma.

  2025cites this paper
• Single-cell and transcriptomic analyses reveal the role of PCDH17 in the non-inflammatory tumor microenvironment of pancreatic cancer

  2025cites this paper
• Integrating AI/ML and multi-omics approaches to investigate the role of TNFRSF10A/TRAILR1 and its potential targets in pancreatic cancer

  2025cites this paper
• Unraveling the Pancreatic Anlagen: Validating a Manual Dissection Protocol with Immunohistochemical Staining for Pancreatic Polypeptide in a Human Cadaver Study

  2025cites this paper
• Smart drug delivery platforms reprogramming cancer immune cycle to mitigate immune resistance of pancreatic tumors.

  2025cites this paper
• PLA2G16 expression predicts prognosis and gemcitabine sensitivity in patients with pancreatic cancer

  2025cites this paper
• The lncRNA ST18-AS1 suppresses pancreatic cancer progression by enhancing ST18 mRNA stability through anchoring FUS in the cytoplasm

  2025cites this paper
• Recent advances in dynamic single-molecule analysis platforms for diagnostics: Advantages over bulk assays and miniaturization approaches.

  2025cites this paper
• In Vitro Anticancer Activities of Curcumin‐Loaded Copper Oxide–Halloysite Nanotubes Composite

  2025cites this paper
• The pancreatitis-cancer transformation-related factor, human rhomboid family-1, promotes pancreatic cancer progression through the SRC/YAP signaling pathway

  2025cites this paper
• Unveiling the multifaceted roles of long non-coding RNA CTBP1-DT in human diseases: Special attention to its microprotein-encoding potential.

  2025cites this paper
• The Role of Yes‐Associated Protein in Inflammatory Diseases and Cancer

  2025cites this paper
• Dual Cascade-Responsive Multifunctional Nanoparticles to Overcome Bacterium-Induced Drug Inactivation and Enhanced Photodynamic and Chemo-Immunotherapy of Pancreatic Cancer.

  2025cites this paper
• Global Status of Research on Quality of Life in Pancreatic Cancer Patients: A Bibliometric and Network Analysis from 2005-2024.

  2025cites this paper
• Plasma treatment can efficiently increase the attachment of pancreatic circulatory tumor cells to the surface

  2025cites this paper
• DNA Origami‐Cyanine Nanocomplex for Precision Imaging of KRAS‐Mutant Pancreatic Cancer Cells

  2025cites this paper
• Serum-derived exosomal miR-7977 combined with miR-451a as a potential biomarker for pancreatic ductal adenocarcinoma

  2025cites this paper
• A systematic review of clinical outcome reporting for curative surgical treatment of patients with pancreatic adenocarcinoma.

  2025cites this paper
• Unveiling FKBP7 as an Early Endoplasmic Reticulum Sentinel in Pancreatic Stellate Cell Activation, Collagen Remodelling and Tumor Progression.

  2025cites this paper
• Rational Design of Metal–Organic Frameworks for Pancreatic Cancer Therapy: from Machine Learning Screening to In Vivo Efficacy

  2025cites this paper
• Laparoscopic radical antegrade modular pancreatosplenectomy vesus laparoscopic distal pancreatosplenectomy for left-sided pancreatic cancer: a systematic review and meta-analysis

  2025cites this paper
• Gemcitabine Alters Phosphatidylcholine Metabolism in Mouse Pancreatic Tumors.

  2025cites this paper
• Revolutionizing pancreatic cancer treatment with CAR-T therapy.

  2025cites this paper
• Mechanisms of antigen-dependent resistance to chimeric antigen receptor (CAR)-T cell therapies

  2025cites this paper
• EIF4E-mediated biogenesis of circPHF14 promotes the growth and metastasis of pancreatic ductal adenocarcinoma via Wnt/β-catenin pathway

  2025cites this paper
• Inflammatory Stimuli and Fecal Microbiota Transplantation Accelerate Pancreatic Carcinogenesis in Transgenic Mice, Accompanied by Changes in the Microbiota Composition

  2025cites this paper
• Pathway-specific genomic alterations in pancreatic cancer across diverse cohorts

  2025cites this paper
• Role of neoadjuvant chemo-radiotherapy for resectable and borderline resectable pancreatic adenocarcinoma- A systematic review and meta-analysis.

  2025cites this paper
• Cross-Talk Between Cancer and Its Cellular Environment—A Role in Cancer Progression

  2025cites this paper
• Targeting the NPY/NPY1R signaling axis in mutant p53–dependent pancreatic cancer impairs metastasis

  2025cites this paper
• Highly multiplexed digital PCR assay for simultaneous quantification of variant allele frequencies and copy number alterations of KRAS and GNAS in pancreatic cancer precursors

  2025cites this paper
• Perioperative and oncologic outcomes after total pancreatectomy and pancreatoduodenectomy for pancreatic head adenocarcinoma-A propensity score-matched analysis from the German Cancer Registry Group.

  2025cites this paper
• TRIP13 protects pancreatic cancer cells against intrinsic and therapy-induced DNA replication stress

  2025cites this paper
• RAW264.7 Macrophages as a Polarization Model in the Context of Pancreatic Cancer and Chemokine Release

  2025cites this paper
• Neoadjuvant treatment versus upfront surgery in borderline resectable and resectable pancreatic ductal adenocarcinoma: meta-analysis

  2025cites this paper
• Identification of key hub genes in pancreatic ductal adenocarcinoma: an integrative bioinformatics study

  2025cites this paper
• Leveraging glycosylation for early detection and therapeutic target discovery in pancreatic cancer

  2025cites this paper
• Integrative insights into the role of CAV1 in ketogenic diet and ferroptosis in pancreatic cancer

  2025cites this paper
• Chlorophyllin exerts synergistic anti-tumor effect with gemcitabine in pancreatic cancer by inducing cuproptosis

  2025cites this paper
• EphA2-targeted alpha-particle theranostics for enhancing PDAC treatment

  2025cites this paper
• Extracellular vesicles-miR-205-5p inhibits lymphatic metastasis in pancreatic cancer through diffusely downregulating VEGFA

  2025cites this paper
• Combining genetic and non-genetic factors to predict the risk of pancreatic cancer in patients with new-onset diabetes mellitus

  2025cites this paper
• Study of antitumor effectiveness of Ras GTPase peptide inhibitor (Inh-Ras) in xenograft model of non-small cell lung cancer

  2025cites this paper
• Single-nucleus RNA sequencing and spatial transcriptomics reveal an immunosuppressive tumor microenvironment related to metastatic dissemination during pancreatic cancer liver metastasis

  2025cites this paper
• Risk Assessment Models for Predicting Venous Thromboembolism in Patients with Pancreatic Cancer

  2025cites this paper